Burt Nabors - Concepedia

Author

Burt Nabors

University of Alabama at Birmingham ORCID

Also Known As

A. Lahti, B Nabors, B. Nabors, Burt NABORS, Burt Nabors, Kendall Morgan, L B Nabors, L B. Nabors, L Burt Nabors, L Burt Nabors, III

622

Publications

19.1K

Citations

H-Index

159

Concepts

All Affiliations

University of Alabama at Birmingham Dana-Farber Cancer Institute Moffitt Cancer Center Neurological Surgery Johns Hopkins University

About

Burt Nabors is an author at University of Alabama at Birmingham specializing in medicine, glioma, and neuro-oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	79	6.8K
2	Health Sciences	17	24	1.8K
3	Natural Sciences	2	2	182
4	Arts	1	1	33
5	Engineering	1	1	114

Burt Nabors

166

Publications

16.2K

Citations

H-Index

Page 1

	Year	Citations
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial Roger Stupp, Monika E. Hegi, Thierry Gorlia, The Lancet Oncology Neuro-oncologyGliomaMedicineStandard TreatmentPathology	2014	1K
Human cytomegalovirus infection and expression in human malignant glioma. Charles Cobbs, Lualhati Harkins, Minu Samanta, PubMed ImmunologyViral PathogenesisPathologyGliomaCancer-associated Virus	2002	719
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma Ingo K. Mellinghoff, Martin J. van den Bent, Deborah T. Blumenthal, New England Journal of Medicine	2023	606
Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma Tracy T. Batchelor, Paul Mulholland, Bart Neyns, Journal of Clinical Oncology	2013	585
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology Burt Nabors, Jana Portnow, Manmeet S. Ahluwalia, Journal of the National Comprehensive Cancer Network Surgical OncologyCancer ManagementHigh-grade GliomasBrain LesionGlioma	2020	538
Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme David A. Reardon, Karen Fink, Tom Mikkelsen, Journal of Clinical Oncology	2008	470
Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States Stuart A. Grossman, Xiaobu Ye, Steven Piantadosi, Clinical Cancer Research	2010	444
A Phase I Open-Label, Dose-Escalation, Multi-Institutional Trial of Injection with an E1B-Attenuated Adenovirus, ONYX-015, into the Peritumoral Region of Recurrent Malignant Gliomas, in the Adjuvant Setting E. Antonio Chiocca, Khalid M. Abbed, Stephen B. Tatter, Molecular Therapy	2004	434
Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells Dan A. Dixon, Neal D. Tolley, Peter H. King, Journal of Clinical Investigation PathologyCancer BiologyTumor BiologyOncologyColon Cancer Cells	2001	433
Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBM James M. Markert, Peter Liechty, Wenquan Wang, Molecular Therapy	2008	398

Page 1